Major depressive disorder: Similar remission rates with bupropion, sertraline, or venlafaxine following treatment switch from citalopram - Commentary

Evidence-Based Mental Health

Volumn 9, Issue 4, 2006, Pages 100-

  Papakostas, George I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248643851     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.9.4.100     Document Type: Note

References (2)

1. Petersen T, Papakostas GI, Posternak MA, et al. Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharmacol 2005;25:336-41. (Pubitemid 41060253)
2. Rush AJ, Fava M, Wisniewski SR, et al, STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 2004;25:119-42. (Pubitemid 38230109)